![Thymoglobulin [Anti-thymocyte Globulin (Rabbit)] Thymoglobulin [Anti-thymocyte Globulin (Rabbit)] logo](/Images/mobile/thymo-logo.png)
- Important Safety Information
- Prescribing Information
- For U.S. Healthcare Professionals Only
Appropriate dosing for Thymoglobulin is different from dosing for other anti-thymocyte globulin (ATG) products, as protein composition and concentrations vary depending on the source of ATG used. Physicians should therefore exercise care to ensure that the dose prescribed is appropriate for the ATG product being administered.1
The immunodeficiency that results from immunosuppression predisposes patients to disorders of immune surveillance and response, including infection and malignancy. The increased risk of infection and malignancy are related more to the overall intensity of immunosuppression than to any specific agent.2,3
During Thymoglobulin therapy, monitoring total lymphocyte count may help assess the degree of T-cell depletion.1
WARNING: IMMUNOSUPPRESSION. Thymoglobulin should only be used by physicians experienced in immunosuppressive therapy in transplantation.
WARNING: IMMUNOSUPPRESSION. Thymoglobulin should only be used by physicians experienced in immunosuppressive therapy in transplantation.
Click here for full Prescribing Information including Boxed WARNING.
Abbreviations: WBC, white blood cell.
References: